Condition	Link to Additional Trial Information
Acute Bleeding During Aortic Replacement Surgery	Haemocomplettan® P During Aortic Replacement
Anticoagulant Reversal	Efficacy and Safety Study of BERIPLEX® P/N Compared With Plasma in Patients on Anticoagulant Therapy Who Require Emergency Surgery or Invasive Intervention
Acute Myeloid Leukemia	Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia
Blood Coagulation Disorders; Acute Major Bleeding	Efficacy and Safety Study of BERIPLEX® P/N Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy
Congenital Fibrinogen Deficiency	Fibrinogen Concentrate (Human) − Efficacy and Safety Study
Emphysema Caused by API Deficiency	Study of Zemaira i.v. Administration in Subjects Who Completed a 2-Year Controlled Study With This Treatment and Have Emphysema Due to alpha1 -Proteinase Inhibitor Deficiency.
Emphysema Caused by API Deficiency	Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency
Factor XIII Deficiency	A Study of the Use of Factor XIII Concentrate in Patients with Inherited FXIII Deficiency
Factor XIII Deficiency	A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
Healthy Volunteers - Adults aged 65 years or younger	A Study of the Efficacy, Safety and Tolerability of CSL Limited's Influenza Virus Vaccine Administered Intramuscularly in Healthy Adults
Healthy Volunteers - Adults aged 65 years or younger	A Study to Determine the Immunogenicity and Safety of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine
Healthy Volunteers - Paediatric	Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged Between >= 6 Months to < 18 Years
Healthy Volunteers - Paediatric	A Study to Determine the Immunogenicity and Safety of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population
Healthy Volunteers - Paediatric	A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children
Healthy Volunteers - Paediatric	A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA
Healthy Volunteers - Adults aged 18 years and older	A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults
Healthy Volunteers - Adults aged 18 years and older	A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA
Hemophilia A	Study of a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII) , Biostate®, in Subjects with Hemophilia A
Hereditary Angioedema	C1 Esterase Inhibitor in HAE (Extension Study)
Primary Immune Deficiency	Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
Primary Immune Deficiency	Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) Requiring IgG Replacement Therapy (North America)
Primary Immune Deficiency	Extension study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Europe)
Primary Immune Deficiency	Subcutaneous Ig NextGen 16% in PID Patients
Primary Immune Deficiency	Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
Von Willebrand Disease	Study of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII), Biostate®, in Subjects With Von Willebrand Disease